{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Effect+Neonatal&page=23", "query": { "condition": "Effect Neonatal", "page": 23 }, "page_size": 10 }, "pagination": { "page": 23, "page_size": 10, "total_count": 856, "total_pages": 86, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Effect+Neonatal&page=24&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Effect+Neonatal&page=22&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-28T09:07:44.863Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00946478", "title": "Effect of Pimecrolimus Cream on Cathelicidin Levels in Subjects With Eczema", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Atopic Dermatitis" ], "interventions": [ { "name": "Pimecrolimus", "type": "DRUG" }, { "name": "Vehicle cream", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 40, "start_date": "2009-10", "completion_date": "2011-05", "has_results": true, "last_update_posted_date": "2014-03-10", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 1, "location_summary": "La Jolla, California", "locations": [ { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00946478" }, { "nct_id": "NCT00473200", "title": "Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Hyperhomocysteinemia" ], "interventions": [ { "name": "S-adenosylmethionine", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Baylor Research Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2009-08", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2018-03-14", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00473200" }, { "nct_id": "NCT04325802", "title": "Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Atopic Dermatitis", "Pruritus", "Pruritus Chronic", "Dermatitis" ], "interventions": [ { "name": "Naltrexone", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 0, "start_date": "2022-12-31", "completion_date": "2024-06", "has_results": false, "last_update_posted_date": "2023-04-04", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT04325802" }, { "nct_id": "NCT01367834", "title": "Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Turner Syndrome" ], "interventions": [ { "name": "somatotropin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Rebecca Knickmeyer Santelli, PhD", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "11 Months", "maximum_age": "13 Months", "sex": "FEMALE", "summary": "11 Months to 13 Months · Female only" }, "enrollment_count": 17, "start_date": "2010-05", "completion_date": "2014-05", "has_results": true, "last_update_posted_date": "2017-03-24", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 1, "location_summary": "Chapel Hill, North Carolina", "locations": [ { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01367834" }, { "nct_id": "NCT02770807", "title": "Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Telangiectasia Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Nervous System Disease", "Genetic Syndrome" ], "interventions": [ { "name": "EryDex Low dose DSP", "type": "DRUG" }, { "name": "EryDex High dose DSP", "type": "DRUG" }, { "name": "Pooled Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Quince Therapeutics S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": null, "sex": "ALL", "summary": "6 Years and older" }, "enrollment_count": 176, "start_date": "2017-03-02", "completion_date": "2021-05-13", "has_results": true, "last_update_posted_date": "2024-05-10", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 4, "location_summary": "Los Angeles, California • Baltimore, Maryland • Cincinnati, Ohio + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02770807" }, { "nct_id": "NCT01061775", "title": "Effects of Exenatide on Hypothalamic Obesity", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Hypothalamic Obesity" ], "interventions": [ { "name": "Exenatide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospitals and Clinics of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "10 Years to 21 Years" }, "enrollment_count": 19, "start_date": "2010-01", "completion_date": "2019-03-15", "has_results": true, "last_update_posted_date": "2019-10-08", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 2, "location_summary": "Orange, California • Saint Paul, Minnesota", "locations": [ { "city": "Orange", "state": "California" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01061775" }, { "nct_id": "NCT03975829", "title": "Pediatric Long-Term Follow-up and Rollover Study", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diffuse Astrocytoma", "Anaplastic Astrocytoma", "Astrocytoma", "Oligodendroglioma, Childhood", "Anaplastic Oligodendroglioma", "Glioblastoma", "Pilocytic Astrocytoma", "Giant Cell Astrocytoma", "Pleomorphic Xanthoastrocytoma", "Anaplastic Pleomorphic Xanthoastrocytoma", "Angiocentric Glioma", "Chordoid Glioma of Third Ventricle", "Gangliocytoma", "Ganglioglioma", "Anaplastic Ganglioglioma", "Dysplastic Gangliocytoma of Cerebrellum", "Desmoplastic Infantile Astrocytoma and Ganglioglioma", "Papillary Glioneuronal Tumor", "Rosette-forming Glioneuronal Tumor", "Central Neurocytoma", "Extraventricular Neurocytoma", "Cerebellar Liponeurocytoma", "Neurofibromatosis Type 1" ], "interventions": [ { "name": "dabrafenib", "type": "DRUG" }, { "name": "trametinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "99 Years", "sex": "ALL", "summary": "1 Year to 99 Years" }, "enrollment_count": 163, "start_date": "2019-11-04", "completion_date": "2026-11-05", "has_results": false, "last_update_posted_date": "2026-08-27", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Washington D.C., District of Columbia • Miami, Florida + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Miami", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT03975829" }, { "nct_id": "NCT01310153", "title": "Effect of Supine or Prone Position After Caesarean Birth", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Respiratory Distress", "Transient Tachypnea of the Newborn", "Delayed Transition of the Newborn", "Persistent Pulmonary Hypertension" ], "interventions": [ { "name": "prone positioning", "type": "PROCEDURE" }, { "name": "Supine", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 65, "start_date": "2006-09", "completion_date": "2009-02", "has_results": false, "last_update_posted_date": "2018-08-31", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01310153" }, { "nct_id": "NCT01353313", "title": "Hydrocortisone for BPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infant, Newborn", "Infant, Small for Gestational Age", "Infant, Very Low Birth Weight", "Infant, Premature", "Bronchopulmonary Dysplasia" ], "interventions": [ { "name": "Hydrocortisone", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NICHD Neonatal Research Network", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "30 Weeks", "sex": "ALL", "summary": "Up to 30 Weeks" }, "enrollment_count": 800, "start_date": "2011-08-11", "completion_date": "2024-09-12", "has_results": true, "last_update_posted_date": "2025-02-27", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Los Angeles, California • Palo Alto, California + 16 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01353313" }, { "nct_id": "NCT02502201", "title": "Environment Effect on Six-Minute Walk Test Performance", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Alpha-1 Antitrypsin Deficiency" ], "interventions": [ { "name": "six-minute walk study indoors", "type": "OTHER" }, { "name": "six-minute walk study outdoors", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 27, "start_date": "2015-10", "completion_date": "2017-08-30", "has_results": false, "last_update_posted_date": "2019-08-22", "last_synced_at": "2026-10-28T09:07:44.863Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02502201" } ] }